The study’s observation of increased CD8+ T cell abundance following TIGIT antibody treatment may denote heightened immune cell infiltration and activity within the tumor, suggestive of TIGIT antibody’s potential to reverse T cell exhaustion. The gene discussed is CD8A; the disease is neoplasm.